Cargando…
IFN-γ alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils
The cytokine interferon-γ (IFN-γ) is approved as a drug to treat chronic granulomatous disease (CGD) and osteopetrosis and is also used in hyperimmunoglobulin E syndromes. Patients with CGD have defects in proteins of the NOX2 NADPH oxidase system. This leads to reduced production of microbicidal RO...
Autores principales: | Ellison, Michael A., Gearheart, Christy M., Porter, Christopher C., Ambruso, Daniel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628906/ https://www.ncbi.nlm.nih.gov/pubmed/28982143 http://dx.doi.org/10.1371/journal.pone.0185956 |
Ejemplares similares
-
INF-γ Enhances Nox2 Activity by Upregulating phox Proteins When Applied to Differentiating PLB-985 Cells but Does Not Induce Nox2 Activity by Itself
por: Ellison, Michael A., et al.
Publicado: (2015) -
In vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype
por: Ambruso, Daniel R., et al.
Publicado: (2022) -
Blockade Effects of Anti-Interferon- (IFN-) γ Autoantibodies on IFN-γ-Regulated Antimicrobial Immunity
por: Krisnawati, Dyah Ika, et al.
Publicado: (2019) -
Neutrophil Maturation and Survival Is Controlled by IFN-Dependent Regulation of NAMPT Signaling
por: Siakaeva, Elena, et al.
Publicado: (2019) -
Design of a DNA-based shift register
por: Gearheart, Christy M, et al.
Publicado: (2010)